Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Would make sense to clean up the arrangement prior to M&A, good point
Maybe there was an ongoing fee for licensing that we didn’t need to continue to incur? We built the robot and own the patents for the tech so it’s time to sunset our dependency on the license? Conflict as a Center of Excellence? I’m not worried especially given it was Titan’s decision.
Updated corporate presentation on the website. Only had time for a quick scan, but appears it is largely the same.
https://titanmedicalinc.com/wp-content/uploads/2017/11/Titan-Medical-Investor-Presentation-November-2017.pdf
We still need near-term news on the following items:
Strasbourg placement and initial feedback
Columbia feedback (academic institution so will absolutely take longer than Nicholson). Keep in mind that Columbia received an advanced prototype, so we could be hearing some very exciting things once we do.
Like Flenderson said, I assume this (Monday) will be a general update across the board. All ducks are in a row and I think they (McNally) simply want to remove some of the uncertainty that keeps share price somewhat bottled.
They won't announce design freeze until trials are through. Assuming no major changes and an efficient documentation process for submission, we should be well ahead on timing.
What constitutes a 'big buy' to you? Keep in mind this is retail money.
Institutional investors (with uplist) will change the order landscape.
Whether this is a normally scheduled call or not, my gut is that we are in a very positive place and management is excited to share progress. This is a CONFIDENCE call. I? plan to add tomorrow.
Looks like Barker was a big piece of the private placement pie for insiders. 261k shares at $0.25/per. After seeing his prowess as the interim CEO to right the ship in a hurry, it's nice to see him still pouring capital into Titan a year later.
https://www.canadianinsider.com/company?menu_tickersearch=TMD%20%7C%20Titan%20Medical
You should take a look at recent job postings by both Verb and J&J/Ethicon. Postings for regulatory affairs for CE and FDA coordination and execution, electrical engineers to manage 'partnerships across multiple platforms' in what J&J is now referring to as their 'digital surgery franchise' and Verb in their 'robotic-assisted digital surgery platform.'
I still don't believe we are 'the Verb robot' but I think we have a very good shot at being a pioneer on the software platform.
Good points. Very easy to get lost in the volatility and the daily fluctuations. Especially when new people come to the board and rattle the cage.
That being said, this is a VERY exciting time to be an investor in TITXF. Finally, after years of holding, we have a magnificent, technologically superior robot that will break through the barriers of cost, competition, data analytics, visualization, improved patient outcomes, and the list goes on.
We are in 3 of the finest robotic centers in the world, with the best surgeons lining up to test and praise SPORT. We have money 'sufficiently through the end of 2017' but likely well into Q1 and look to be making great progress against our timeline.
Saddle up longs, we're headed north!
Potential that Titan is cleaning up their language as they prep for FDA.
https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/SurgeryandLifeSupport/ComputerAssistedSurgicalSystems/default.htm
So it looks like he added 500k shares and now has a balance of 1,971,500 shares.
Based on previous filings (e.g. Longtai) I believe that’s # shares.
Invest, thanks for the info. Where do you see that much being purchased? I see “only” 500k shares on C insider. Thanks
Mazor PPS is ~$54 per share but market cap is only $1.4 billion. That would be roughly equivalent to ~$5 per share for Titan, so may take a bit to get to $50 per share.
Hoping for a gap to $0.40+ on Monday morning and a quick run to $0.50. No reason this can't push to $1 quickly. $300 mil market cap seems perfectly reasonable at this stage all things considered.
Tough to see TRXC ride higher with such an inferior platform. However, based on where they originally reversed to, investors are likely still down 65-75%.
Great news for the space, hopefully some new articles in mainstream outlets attract attention and call out Titan as a competitor.
TRXC's market cap has also swelled to nearly $700 million on these runs which is great for Titan.
I’m actually in the camp that believes there is no connection, but there are so many coincidences and the list grows weekly. Sport and Orep, look up recent ethicon job postings for marketing positions for this endeavor.
J&J is now calling it the “Launch Excellence Process”. Titan aptly names their clinical sites “Centers of Excellence”. Hardly a match but the language continues to run parallel.
I think we have a shot at being one of many robots on a very robust Verb platform.
Power close!
can you send the backup for that?
i'm just going by otcshortreport.com
Unfortunately, the shorts are still holding us back.
http://otcshortreport.com/company/TITXF?index=TITXF&action=view
Have to hope strong, bullish volume continues and shakes them out. Methodical PRs are certainly helping, but we will need to address financing and in all likelihood, that's what they're playing. Mc needs to get creative. Let's go TITXF!
Some interesting Ethicon patents recently and across 2017. Any med professionals have an opinion?
http://stks.freshpatents.com/Ethicon-Endo-surgery-Inc-nm1.php
Quid, 66, and to whomever found Teton Funds, if you dig a little more on the Mighty Mites Fund, you will see that the portfolio manager is none other than legendary investor, Mario Gabelli. For those of you who work in the industry, you know he's a titan of industry. I love seeing this.
This would certainly spark interest by any mainstream financial news outlet. Morningstar shows they own only 5,000 shares as of 3/31, but Morningstar also shows that Longtai owns 247 million shares as of 7/31. Clearly a data integrity issue.
SPORT installed!
News to me. Thanks, sunshine.
Paige is finally gone from the website.
Agree with your points. However, this whole operation is secretive and carries an extremely high beta. Of the risks we face now, we all knew they were inherent. Prior mgmt blew and things have changed unfortunately a number of times. I feel your pain and carry many shares at a significant loss. Pretty binary IMO. But debt is a death knell. Doesn't mean I'm happy with fundraising situation. Also I think no matter the financing situation, you still can't disclose much of anything.
Why would you want debt? In the event of default you have no claim as a common shareholder. This would be bad. I don't know what y'all expect from McNally. There is progress and there may be updates. There are certainly no updates from any other platform in R&D. Including Verb. Medtronic? Nada.
i believe that's just disclosure in their local currency. i haven't seen any info on the investor participation. just curious.
How do you know there was zero US money?
I think the primary goal of uplisting is to attract institutional US money and build momentum. New base of investors who otherwise haven't been able to allocate here. Also, if you read the uplist requirements, you'll note that we can't uplist at this point based on the shareholder approval we currently have in place.
This is a speculative trade right now, and will be treated just like the other spec stocks on the NASDAQ that are pre-earnings and trade on whispers, news, and momentum. Discussing earnings doesn't seem relevant. I wouldn't put my money in this based on any fundamental analysis.
And I think we all know it can be crickets for months then Titan could be acquired by a big player overnight. We just don't know and I've said it before, the news flows on ALL of these platforms under development is next to nothing. Titan just happens to be public and faces backlash from previously poor mgmt decisions and ongoing cap raise. Double whammy.
Shorts are DEAD! Let's hope this trend continues and demand picks up.
http://otcshortreport.com/?index=TITXF&action=view
Great assessment. Keep in mind that institutional money, for the most part, won't go near this until it is uplisted to a more salient exchange. Most investors, retail or institutional, won't go near this until financing concerns are addressed, or we get adequate progress to dismantle those concerns. I certainly don't believe it's a technology issue. I've always felt that a pivotal moment is deploying the robots to the centers of excellence where there is finally tangible and public content to digest around the system and its performance. Time will tell.
I really don't know. I'm scratching my head here as well. As usual, just limited facts and light details from the company.
Fingers crossed it means alternative financing is imminent or expected.
I confirmed that should Titan raise additional funds through a public offering, Titan will need to file a new prospectus. There is currently no active offering.
Also confirmed that we will hear on the sites by the end of August.
ST or others, have you done any research on this?
I thought the same initially but it seems to me like it's something driven by the issuer.
APPARATUS AND METHOD FOR CONTROLLING AN END-EFFECTOR ASSEMBLY
New patent granted on August 8th. Don't believe it was noted on the board.
https://assignment.uspto.gov/patent/index.html#/patent/search/resultAbstract?id=20140276956&type=publNum
ALSO, one of the assignors, Lawrence Crainich, if you click on him you'll notice the majority of his work is or was with Ethicon.
Agree with your assessment. If there is a best in class robotic surgery innovation center, I want Titan to be there. I actually welcome the competition. Please put the SPORT up next to Senhance. And SP. We are a partner and a client. This is a collaboration and lots of resources are allocated by both sides. I also love the quote we got from Magnuson as opposed to the babble from Eubanks.
I spent a decent amount of time searching for information on Longtai, their CEO, and the parent. I only find that Longtai was registered in Canada just prior to their partnership announcement with Titan in 2015. The address that it's registered to is a residential place in Alberta. I found 3 other registered companies to that address (2 anonymous companies registered in Feb 17).The address in the most recent Titan PR for Longtai is hundreds and hundreds of miles from this address.
I'm scratching my head. Anyone else?
Anything of value in the new applications? I wasn't able to find them.
That's my point. He's not involved. He just doesn't know anything. And he really doesn't make that much $ for a CFO. He knows the history of the company. That's valuable for the accounting side.